Table 1 Baseline characteristics
Variables | N = 618 |
|---|---|
Age (year) | 65 ± 14 |
Male (%) | 70 |
eGFR (mL/min/1.73 m2) | 5.1 ± 2.5 |
BMI (kg/m2) | 23.9 ± 4.6 |
Systolic blood pressure (mmHg) | 147 ± 24 |
Current smoker (%) | 17 |
Past smoker (%) | 29 |
Never smoker (%) | 51 |
Unknown status of smoking (%) | 2 |
Comorbidities | |
Diabetes (%) | 47 |
Coronary artery disease (%) | 10 |
Heart failure (%) | 13 |
Atrial fibrillation (%) | 3 |
Ablation (%) | 1 |
Pacemaker replacement (%) | 0.5 |
Peripheral artery disease (%) | 7 |
Cerebrovascular infarction (%) | 9 |
Cerebrovascular hemorrhage (%) | 3 |
Corrected calcium (mg/dL) | 8.7 ± 0.8 |
Potassium (mEq/L) | 4.5 ± 0.7 |
Phosphate (mg/dL) | 5.7 ± 1.6 |
Magnesium (mg/dL) | 2.3 ± 0.5 |
Prescription | |
Dihydropyridine CCB (%) | 87 |
Non-dihydropyridine CCB (%) | 2 |
β-blocker (%) | 35 |
RAS inhibitors (%) | 54 |
Diuretics (%) | 67 |
Insulin (%) | 19 |